IRF
TVRD

IBM Retirement Fund’s Tvardi Therapeutics TVRD Stock Holding History

IBM Retirement Fund’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-736
Closed -$322K – 488
2022
Q1 		$322K Sell
736
-384
-34% -$158K 0.05% 371
2021
Q4 		$491K Hold
1,120
– – 0.06% 298
2021
Q3 		$623K Hold
1,120
– – 0.05% 352
2021
Q2 		$575K Buy
+1,120
New +$710K 0.05% 376

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IBM Retirement Fund's TVRD Position: Q2 2022 in Review

IBM Retirement Fund sold out of Tvardi Therapeutics (TVRD) in Q2 2022, closing a stake of 736 shares — an estimated $322K sold.

IBM Retirement Fund first reported a position in TVRD in Q2 2021 and held it in 4 quarters. The position peaked at $623K in Q3 2021. 178 funds tracked by Wall St. Rank hold TVRD as of Q2 2022.

  • IBM Retirement Fund reported no remaining Tvardi Therapeutics position as of Q2 2022 after selling out during the quarter.
  • IBM Retirement Fund sold 736 Tvardi Therapeutics shares in Q2 2022, an estimated $322K.
  • IBM Retirement Fund first reported a position in Tvardi Therapeutics in Q2 2021 and held it in 4 quarters.
  • IBM Retirement Fund's Tvardi Therapeutics position peaked at $623K in Q3 2021.
  • 178 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2022.

Based on IBM Retirement Fund's 13F filing for Q2 2022, filed 20 Jul 2022.